2023 Approvals
FDA Approves Bimzelx for Plaque Psoriasis: A New Hope for Patients as of October 17, 2023
What is Bimzelx prescribed for? Bimzelx is prescribed to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. What is Bimzelx and what does it do? Bimzelx, pronounced bim zel’ ex, (generic name: bimekizumab-bkzx) is a medication approved by the FDA to help